FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 349:640-649 August 14, 2003 Number 7 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Perspective by Simone, J. V. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

ABSTRACT

Background Children who survive acute lymphoblastic leukemia are at risk for leukemia-related or treatment-related complications, which can adversely affect survival and socioeconomic status. We determined the long-term survival and the rates of health insurance coverage, marriage, and employment among patients who had attained at least 10 years of event-free survival.

Methods A total of 856 eligible patients were treated between 1962 and 1992 in 13 consecutive clinical trials. Survival rates, the cumulative risk of a second neoplasm, and selected indicators of socioeconomic status were analyzed for the entire group and for patients who did or did not receive cranial or craniospinal radiation therapy during initial treatment.

Results Fifty-six patients had major adverse events, including 8 deaths during remission, 4 relapses, and 44 second neoplasms (41 of them radiation-related); most of the second neoplasms were benign or of a low grade of malignant potential. The risk of a second neoplasm was significantly higher in the 597 patients who received radiation therapy (irradiated group) than in the 259 patients who did not receive radiation therapy (nonirradiated group) (P=0.04; estimated cumulative risk [±SE] at 20 years, 20.9±3.9 percent vs. 0.95±0.9 percent). The death rate for the irradiated group slightly exceeded the expected rate in the general U.S. population (standardized mortality ratio, 1.90; 95 percent confidence interval, 1.12 to 3.00), whereas that for the nonirradiated group did not differ from the population norm (standardized mortality ratio, 1.75; 95 percent confidence interval, 0.34 to 5.00). The rates of health insurance coverage, marriage, and employment in the nonirradiated group were similar to the age- and sex-adjusted national averages. Despite having health insurance rates similar to those in the general population, men and women in the irradiated group had higher-than-average unemployment rates (15.1 percent vs. 5.4 percent and 35.4 percent vs. 5.2 percent, respectively), and women in the irradiated group were less likely to be married (35.2 percent vs. 48.8 percent).

Conclusions Children with acute lymphoblastic leukemia who did not receive radiation therapy and who have attained 10 or more years of event-free survival can expect a normal long-term survival. Irradiation is associated with the development of second neoplasms, a slight excess in mortality, and an increased unemployment rate.

Source Information

From the Departments of Hematology–Oncology (C.-H.P., W.L., G.K.R., J.T.S., R.C.R., M.M.H.), Pathology (C.-H.P.), Biostatistics (C.C., S.N.R.), Pharmaceutical Sciences (M.V.R., W.E.E.), and Radiation Oncology (L.E.K.), St. Jude Children's Research Hospital; and the Colleges of Medicine (C.-H.P., W.L., G.K.R., J.T.S., R.C.R., M.V.R., L.E.K., W.E.E., M.M.H.) and Pharmacy (M.V.R., W.E.E.), University of Tennessee Health Science Center — all in Memphis.

Address reprint requests to Dr. Pui at St. Jude Children's Research Hospital, 332 N. Lauderdale, Memphis, TN 38105, or at ching-hon.pui{at}stjude.org.

Full Text of this Article

Related Letters:

Long-Term Survivors of Acute Lymphoblastic Leukemia
Nuver J., van den Belt-Dusebout A. W., Gietema J. A., Pui C.-H., Evans W. E., Hudson M. M.
Extract | Full Text | PDF  
N Engl J Med 2003; 349:1973, Nov 13, 2003. Correspondence

This article has been cited by other articles:

• Tucci, F., Arico, M. (2008). Treatment of pediatric acute lymphoblastic leukemia. haematol 93: 1124-1128 [Full Text]  
• Thotala, D. K., Hallahan, D. E., Yazlovitskaya, E. M. (2008). Inhibition of Glycogen Synthase Kinase 3{beta} Attenuates Neurocognitive Dysfunction Resulting from Cranial Irradiation. Cancer Res. 68: 5859-5868 [Abstract] [Full Text]  
• Mody, R., Li, S., Dover, D. C., Sallan, S., Leisenring, W., Oeffinger, K. C., Yasui, Y., Robison, L. L., Neglia, J. P. (2008). Twenty-five-year follow-up among survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. Blood 111: 5515-5523 [Abstract] [Full Text]  
• Relling, M. V., Evans, W. E., Pui, C.-H. (2008). Continue to study childhood ALL. Blood 111: 468-469 [Full Text]  
• Waber, D. P., Turek, J., Catania, L., Stevenson, K., Robaey, P., Romero, I., Adams, H., Alyman, C., Jandet-Brunet, C., Neuberg, D. S., Sallan, S. E., Silverman, L. B. (2007). Neuropsychological Outcomes From a Randomized Trial of Triple Intrathecal Chemotherapy Compared With 18 Gy Cranial Radiation As CNS Treatment in Acute Lymphoblastic Leukemia: Findings From Dana-Farber Cancer Institute ALL Consortium Protocol 95-01. JCO 25: 4914-4921 [Abstract] [Full Text]  
• Stanulla, M., Dynybil, C., Bartels, D. B., Dordelmann, M., Loning, L., Claviez, A., Schrappe, M. (2007). The NQO1 C609T polymorphism is associated with risk of secondary malignant neoplasms after treatment for childhood acute lymphoblastic leukemia: a matched-pair analysis from the ALL-BFM study group. haematol 92: 1581-1582 [Abstract] [Full Text]  
• Chauvenet, A. R., Martin, P. L., Devidas, M., Linda, S. B., Bell, B. A., Kurtzberg, J., Pullen, J., Pettenati, M. J., Carroll, A. J., Shuster, J. J., Camitta, B. (2007). Antimetabolite therapy for lesser-risk B-lineage acute lymphoblastic leukemia of childhood: a report from Children's Oncology Group Study P9201. Blood 110: 1105-1111 [Abstract] [Full Text]  
• Oeffinger, K. C., Robison, L. L. (2007). Childhood Cancer Survivors, Late Effects, and a New Model for Understanding Survivorship. JAMA 297: 2762-2764 [Full Text]  
• Maule, M., Scelo, G., Pastore, G., Brennan, P., Hemminki, K., Tracey, E., Sankila, R., Weiderpass, E., Olsen, J. H., McBride, M. L., Brewster, D. H., Pompe-Kirn, V., Kliewer, E. V., Chia, K. S., Tonita, J. M., Martos, C., Jonasson, J. G., Merletti, F., Boffetta, P. (2007). Risk of Second Malignant Neoplasms After Childhood Leukemia and Lymphoma: An International Study. JNCI J Natl Cancer Inst 99: 790-800 [Abstract] [Full Text]  
• Kishi, S., Cheng, C., French, D., Pei, D., Das, S., Cook, E. H., Hijiya, N., Rizzari, C., Rosner, G. L., Frudakis, T., Pui, C.-H., Evans, W. E., Relling, M. V. (2007). Ancestry and pharmacogenetics of antileukemic drug toxicity. Blood 109: 4151-4157 [Abstract] [Full Text]  
• Hijiya, N., Hudson, M. M., Lensing, S., Zacher, M., Onciu, M., Behm, F. G., Razzouk, B. I., Ribeiro, R. C., Rubnitz, J. E., Sandlund, J. T., Rivera, G. K., Evans, W. E., Relling, M. V., Pui, C.-H. (2007). Cumulative Incidence of Secondary Neoplasms as a First Event After Childhood Acute Lymphoblastic Leukemia. JAMA 297: 1207-1215 [Abstract] [Full Text]  
• Moghrabi, A., Levy, D. E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V. K., Lipshultz, S. E., Neuberg, D. S., Gelber, R. D., Cohen, H. J., Sallan, S. E., Silverman, L. B. (2007). Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia. Blood 109: 896-904 [Abstract] [Full Text]  
• Stock, W., Seibel, N. L. (2007). Acute lymphoblastic leukemia and lymphoblastic lymphoma. ASH-SAP 2007: 253-264 [Full Text]  
• Yazlovitskaya, E. M., Edwards, E., Thotala, D., Fu, A., Osusky, K. L., Whetsell, W. O. Jr., Boone, B., Shinohara, E. T., Hallahan, D. E. (2006). Lithium Treatment Prevents Neurocognitive Deficit Resulting from Cranial Irradiation. Cancer Res. 66: 11179-11186 [Abstract] [Full Text]  
• Card, T R, Solaymani-Dodaran, M, Hubbard, R, Logan, R F A, West, J (2006). Is an internal comparison better than using national data when estimating mortality in longitudinal studies?. J. Epidemiol. Community Health 60: 819-821 [Abstract] [Full Text]  
• Spiegler, B. J., Kennedy, K., Maze, R., Greenberg, M. L., Weitzman, S., Hitzler, J. K., Nathan, P. C. (2006). Comparison of Long-Term Neurocognitive Outcomes in Young Children With Acute Lymphoblastic Leukemia Treated With Cranial Radiation or High-Dose or Very High-Dose Intravenous Methotrexate. JCO 24: 3858-3864 [Abstract] [Full Text]  
• Barredo, J. C., Devidas, M., Lauer, S. J., Billett, A., Marymont, M., Pullen, J., Camitta, B., Winick, N., Carroll, W., Ritchey, A. K. (2006). Isolated CNS Relapse of Acute Lymphoblastic Leukemia Treated With Intensive Systemic Chemotherapy and Delayed CNS Radiation: A Pediatric Oncology Group Study. JCO 24: 3142-3149 [Abstract] [Full Text]  
• Meck, M. M., Leary, M., Sills, R. H. (2006). Late Effects in Survivors of Childhood Cancer. Pediatr. Rev. 27: 257-263 [Full Text]  
• Prouty, D., Ward-Smith, P., Hutto, C. J. (2006). The Lived Experience of Adult Survivors of Childhood Cancer. Journal of Pediatric Oncology Nursing 23: 143-151 [Abstract]  
• Burkhardt, B., Woessmann, W., Zimmermann, M., Kontny, U., Vormoor, J., Doerffel, W., Mann, G., Henze, G., Niggli, F., Ludwig, W.-D., Janssen, D., Riehm, H., Schrappe, M., Reiter, A. (2006). Impact of Cranial Radiotherapy on Central Nervous System Prophylaxis in Children and Adolescents With Central Nervous System-Negative Stage III or IV Lymphoblastic Lymphoma. JCO 24: 491-499 [Abstract] [Full Text]  
• Pui, C.-H., Evans, W. E. (2006). Treatment of Acute Lymphoblastic Leukemia. NEJM 354: 166-178 [Full Text]  
• Viscomi, S., Pastore, G., Dama, E., Zuccolo, L., Pearce, N., Merletti, F., Magnani, C. (2006). Life expectancy as an indicator of outcome in follow-up of population-based cancer registries: the example of childhood leukemia. Ann Oncol 17: 167-171 [Abstract] [Full Text]  
• Pui, C.-H. (2006). Central Nervous System Disease in Acute Lymphoblastic Leukemia: Prophylaxis and Treatment. ASH Education Book 2006: 142-146 [Abstract] [Full Text]  
• Park, E. R., Li, F. P., Liu, Y., Emmons, K. M., Ablin, A., Robison, L. L., Mertens, A. C. (2005). Health Insurance Coverage in Survivors of Childhood Cancer: The Childhood Cancer Survivor Study. JCO 23: 9187-9197 [Abstract] [Full Text]  
• Pui, C.-H., Pei, D., Sandlund, J. T., Campana, D., Ribeiro, R. C., Razzouk, B. I., Rubnitz, J. E., Howard, S. C., Hijiya, N., Jeha, S., Cheng, C., Downing, J. R., Evans, W. E., Relling, M. V., Hudson, M. (2005). Risk of Adverse Events After Completion of Therapy for Childhood Acute Lymphoblastic Leukemia. JCO 23: 7936-7941 [Abstract] [Full Text]  
• Castellino, S. M., Casillas, J., Hudson, M. M., Mertens, A. C., Whitton, J., Brooks, S. L., Zeltzer, L. K., Ablin, A., Castleberry, R., Hobbie, W., Kaste, S., Robison, L. L., Oeffinger, K. C. (2005). Minority Adult Survivors of Childhood Cancer: A Comparison of Long-Term Outcomes, Health Care Utilization, and Health-Related Behaviors From the Childhood Cancer Survivor Study. JCO 23: 6499-6507 [Abstract] [Full Text]  
• Rocha, J. C. C., Cheng, C., Liu, W., Kishi, S., Das, S., Cook, E. H., Sandlund, J. T., Rubnitz, J., Ribeiro, R., Campana, D., Pui, C.-H., Evans, W. E., Relling, M. V. (2005). Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 105: 4752-4758 [Abstract] [Full Text]  
• Ribeiro, R. C., Pui, C.-H. (2005). Saving the Children -- Improving Childhood Cancer Treatment in Developing Countries. NEJM 352: 2158-2160 [Full Text]  
• Shankar, S., Robison, L., Jenney, M. E.M., Rockwood, T. H., Wu, E., Feusner, J., Friedman, D., Kane, R. L., Bhatia, S. (2005). Health-Related Quality of Life in Young Survivors of Childhood Cancer Using the Minneapolis-Manchester Quality of Life-Youth Form. Pediatrics 115: 435-442 [Abstract] [Full Text]  
• Pui, C.-H., Sandlund, J. T., Pei, D., Campana, D., Rivera, G. K., Ribeiro, R. C., Rubnitz, J. E., Razzouk, B. I., Howard, S. C., Hudson, M. M., Cheng, C., Kun, L. E., Raimondi, S. C., Behm, F. G., Downing, J. R., Relling, M. V., Evans, W. E. (2004). Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital. Blood 104: 2690-2696 [Abstract] [Full Text]  
• Oeffinger, K. C., Hudson, M. M. (2004). Long-term Complications Following Childhood and Adolescent Cancer: Foundations for Providing Risk-based Health Care for Survivors. CA Cancer J Clin 54: 208-236 [Abstract] [Full Text]  
• Rice, S. C., Vacek, P., Homans, A. H., Messier, T., Rivers, J., Kendall, H., Finette, B. A. (2004). Genotoxicity of Therapeutic Intervention in Children with Acute Lymphocytic Leukemia. Cancer Res. 64: 4464-4471 [Abstract] [Full Text]  
• Kirsch, D. G., Tarbell, N. J. (2004). Conformal Radiation Therapy for Childhood CNS Tumors. The Oncologist 9: 442-450 [Abstract] [Full Text]  
• Hudson, M. M., Hester, A., Sweeney, T., Kippenbrock, S., Majcina, R., Vear, S., Wiard, S., Kaplan, S. (2004). A Model of Care for Childhood Cancer Survivors That Facilitates Research. Journal of Pediatric Oncology Nursing 21: 170-174 [Abstract]  
• Sonmezer, M., Oktay, K. (2004). Fertility preservation in female patients. Hum Reprod Update 10: 251-266 [Abstract] [Full Text]  
• Pui, C.-H., Relling, M. V., Downing, J. R. (2004). Acute Lymphoblastic Leukemia. NEJM 350: 1535-1548 [Full Text]  
• (2004). Long-term survivors of acute lymphoblastic leukaemia. Arch. Dis. Child. 89: 237-237 [Full Text]  
• Pui, C.-H., Schrappe, M., Ribeiro, R. C., Niemeyer, C. M. (2004). Childhood and Adolescent Lymphoid and Myeloid Leukemia. ASH Education Book 2004: 118-145 [Abstract] [Full Text]  
• Nuver, J., van den Belt-Dusebout, A. W., Gietema, J. A., Pui, C.-H., Evans, W. E., Hudson, M. M. (2003). Long-Term Survivors of Acute Lymphoblastic Leukemia. NEJM 349: 1973-1973 [Full Text]